Found: 178
Select item for more details and to access through your institution.
Introduction.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 6, p. 511, doi. 10.1007/s10637-005-4018-2
- By:
- Publication type:
- Article
The Role of an Androgen Receptor Polymorphism in the Clinical Outcome of Patients with Metastatic Prostate Cancer.
- Published in:
- Urologia Internationalis, 2002, v. 68, n. 1, p. 16, doi. 10.1159/000048412
- By:
- Publication type:
- Article
A Phase II Trial of Gallium Nitrate in Patients with Androgen-Metastatic Prostate Cancer.
- Published in:
- Urologia Internationalis, 1999, v. 63, n. 2, p. 120, doi. 10.1159/000030430
- By:
- Publication type:
- Article
Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 833, doi. 10.1002/ajh.26527
- By:
- Publication type:
- Article
Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer.
- Published in:
- Journal of Racial & Ethnic Health Disparities, 2024, v. 11, n. 1, p. 492, doi. 10.1007/s40615-023-01534-4
- By:
- Publication type:
- Article
Integrating pharmacogenetic information and clinical decision support into the electronic health record.
- Published in:
- Journal of the American Medical Informatics Association, 2014, v. 21, n. 3, p. 522, doi. 10.1136/amiajnl-2013-001873
- By:
- Publication type:
- Article
The Role of MRI in Prostate Cancer Active Surveillance.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/203906
- By:
- Publication type:
- Article
Androgen receptor splice variant 7 (AR‐V7) and AR full‐length (AR‐FL) as predictive biomarkers of therapeutic resistance: partners in crime?
- Published in:
- BJU International, 2019, v. 124, n. 4, p. 549, doi. 10.1111/bju.14869
- By:
- Publication type:
- Article
A phase I study of TRC105 anti-endoglin ( CD105) antibody in metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2015, v. 116, n. 4, p. 546, doi. 10.1111/bju.12986
- By:
- Publication type:
- Article
Detection of Extracellular Vesicle-Derived RNA as Potential Prostate Cancer Biomarkers: Role of Cancer-type SLCO1B3 and ABCC3.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 3, p. 615, doi. 10.7150/jca.90836
- By:
- Publication type:
- Article
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 4, p. 1, doi. 10.1038/s41419-022-04868-9
- By:
- Publication type:
- Article
A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2015, v. 14, n. 3, p. 154, doi. 10.1016/j.clcc.2015.02.007
- By:
- Publication type:
- Article
Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 2, p. 192, doi. 10.1016/j.clpt.2006.05.003
- By:
- Publication type:
- Article
The 2005 Leon I. Goldberg Young Investigator Award Lecture: Development of thalidomide as an angiogenesis inhibitor for the treatment of androgen-independent prostate cancer<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 1, p. 1, doi. 10.1016/j.clpt.2005.09.006
- By:
- Publication type:
- Article
Relationship of systemic exposure to unbound docetaxel and neutropenia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 43, doi. 10.1016/j.clpt.2004.09.005
- By:
- Publication type:
- Article
Disposition of polyoxyethylated excipients in humans: Implications for drug safety and formulation approaches.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 5, p. 509, doi. 10.1016/j.clpt.2003.08.004
- By:
- Publication type:
- Article
Preliminary Pharmacokinetics (PK) of COL-3, A Matrix Metalloproteinase (MMP) Inhibitor.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 2, p. 195, doi. 10.1016/S0009-9236(99)80308-7
- By:
- Publication type:
- Article
Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs.
- Published in:
- FASEB Journal, 2020, v. 34, n. 9, p. 11395, doi. 10.1096/fj.201903060RR
- By:
- Publication type:
- Article
Reviewing the role of healthy volunteer studies in drug development.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Polypharmacy in View of Advances in Cancer Treatment.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 9, p. 1055
- By:
- Publication type:
- Article
Sifting Through the Multitude of Novel Therapies for Prostate Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1792
- By:
- Publication type:
- Article
A high-performance liquid chromatography method using ultraviolet detection for the quantitation of flavopiridol from human plasma.
- Published in:
- Biomedical Chromatography, 2002, v. 16, n. 6, p. 379, doi. 10.1002/bmc.166
- By:
- Publication type:
- Article
A high-performance liquid chromatography method using ultraviolet and fluorescence detection for the quantitation of UCN-01, 7-hydroxystaurosporine, from human plasma and saliva.
- Published in:
- Biomedical Chromatography, 2000, v. 14, n. 5, p. 338, doi. 10.1002/1099-0801(200008)14:5<338::AID-BMC993>3.0.CO;2-6
- By:
- Publication type:
- Article
Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs.
- Published in:
- Molecules, 2020, v. 25, n. 23, p. 5683, doi. 10.3390/molecules25235683
- By:
- Publication type:
- Article
Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 625, p. 1, doi. 10.1126/scitranslmed.abd8077
- By:
- Publication type:
- Article
CPS49-induced neurotoxicity does not cause limb patterning anomalies in developing chicken embryos.
- Published in:
- Journal of Anatomy, 2018, v. 232, n. 4, p. 568, doi. 10.1111/joa.12712
- By:
- Publication type:
- Article
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat.
- Published in:
- ChemMedChem, 2021, v. 16, n. 13, p. 2082, doi. 10.1002/cmdc.202100133
- By:
- Publication type:
- Article
Synthesis, Structural Characterization, and Antiangiogenic Activity of Polyfluorinated Benzamides.
- Published in:
- ChemMedChem, 2018, v. 13, n. 19, p. 2080, doi. 10.1002/cmdc.201800263
- By:
- Publication type:
- Article
Alendronate Does Not Interfere with <sup>99m</sup>Tc-Methylene Diphosphonate Bone Scanning.
- Published in:
- Journal of Nuclear Medicine, 2001, v. 42, n. 9, p. 1359
- By:
- Publication type:
- Article
Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)n Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 3, p. 896, doi. 10.3390/ijms21030896
- By:
- Publication type:
- Article
Reversible sideroblastic anemia associated with the tetracycline analogue COL-3.
- Published in:
- American Journal of Hematology, 2001, v. 67, n. 1, p. 51, doi. 10.1002/ajh.1076
- By:
- Publication type:
- Article
Severe thrombocytopenia in patients treated with suramin: Evidence for an immune mechanism in one.
- Published in:
- American Journal of Hematology, 1996, v. 51, n. 2, p. 152, doi. 10.1002/(SICI)1096-8652(199602)51:2<152::AID-AJH10>3.0.CO;2-K
- By:
- Publication type:
- Article
Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 22, p. 1698, doi. 10.1093/jnci/djq390
- By:
- Publication type:
- Article
Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Hormone-Refractory Prostate Cancer: Where are We Going?
- Published in:
- Drugs, 2007, v. 67, n. 8, p. 1109, doi. 10.2165/00003495-200767080-00002
- By:
- Publication type:
- Article
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02649-6
- By:
- Publication type:
- Article
Local and Systemic Antitumor Effects of Photo‐activatable Paclitaxel Prodrug on Rat Breast Tumor Models.
- Published in:
- Photochemistry & Photobiology, 2020, v. 96, n. 3, p. 668, doi. 10.1111/php.13202
- By:
- Publication type:
- Article
Interventional pharmacoeconomics for immune checkpoint inhibitors through alternative dosing strategies.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1389, doi. 10.1038/s41416-023-02367-y
- By:
- Publication type:
- Article
Genomic Characterization of Preclinical Prostate Cancer Cell Line Models.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6111, doi. 10.3390/ijms25116111
- By:
- Publication type:
- Article
Recent advances in pharmacogenetic approaches to anticancer drug development.
- Published in:
- Drug Development Research, 2004, v. 62, n. 3, p. 233, doi. 10.1002/ddr.10361
- By:
- Publication type:
- Article
Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Phase l/lb Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 6, p. 1, doi. 10.1093/jnci/dju089
- By:
- Publication type:
- Article
Subcutaneous Atezolizumab: A Jab Without a Benefit.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 1, p. 134, doi. 10.1002/cpdd.1061
- By:
- Publication type:
- Article
CECs and IL-8 have prognostic and predictive utility in patients with recurrent platinum-sensitive ovarian cancer: biomarker correlates from the randomized phase-2 trial of olaparib and cediranib compared with olaparib in recurrent platinum-sensitive ovarian cancer
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00123
- By:
- Publication type:
- Article
Reactive astrocytic S1P3 signaling modulates the blood–tumor barrier in brain metastases.
- Published in:
- Nature Communications, 2018, v. 9, p. 1, doi. 10.1038/s41467-018-05030-w
- By:
- Publication type:
- Article
A Phase I/II Study of High-Dose Tamoxifen in Combination with Vinblastine in Patients with Androgen-Independent Prostate Cancer.
- Published in:
- Acta Oncologica, 2003, v. 42, n. 3, p. 195, doi. 10.1080/02841860310010718
- By:
- Publication type:
- Article
Flutamide Withdrawal and Concomitant Initiation of Aminoglutethimide in Patients with Hormone Refractory Prostate Cancer.
- Published in:
- Acta Oncologica, 1996, v. 35, n. 6, p. 763, doi. 10.3109/02841869609084015
- By:
- Publication type:
- Article
Clinical protocol: Feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysis.
- Published in:
- PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0291068
- By:
- Publication type:
- Article
Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2010, v. 148, n. 2, p. 256, doi. 10.1111/j.1365-2141.2009.07954.x
- By:
- Publication type:
- Article